|D045169||Severe Acute Respiratory Syndrome NIH||0.05|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
This multicentre prospective cohort trial is designed to demonstrate effectiveness and efficiency of a virtual care model for the management of COVID-19 patients isolating at home. The investigators have reoriented existing technology and networks for this research project. The investigators are amplifying our existing virtual care platform VIRTUES, combining it with home monitoring of COVID-19 patients, to provide real-time evidence, harmonize data collection, and share data provincially to mitigate the impact of the rapid spread of the virus. The study will facilitate early detection of complications associated with the disease, treatment and management of COVID-19 patients at home. The research will be conducted provincially in Ontario. This initiative will provide evidence to inform clinical and health system management and public health response to COVID-19 patients isolating at home.
Description: The primary outcome measure is patient satisfaction as measured from a patient satisfaction questionnaire at 28 days.Measure: 28 Day Patient Satisfaction Questionnaire Time: 28 days
Description: The secondary outcome measures will include the number of patients that require an Emergency Department visits during the observation period of 28 days.Measure: Emergency Department Visits Time: 28 days
Description: The secondary outcome measures will include the health status measures of the EuroQuality of Life Five Dimensions (EQ-5D-5L) at 28 days. Scoring is Level 1 to 5 for each dimension; higher scores meaning worse health status.Measure: 28 Day EQ-5D-5L Scores Time: 28 days